Public Company News

Xaxis Uses IAS's Context Control Targeting to Raise Awareness for a Fashion Brand

TAIPEI, Jan. 11, 2022 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a global leader in digital media quality, and Xaxis, GroupM's outcome media specialist, used Context Control Targeting to increase campaign performance, website traffic, and brand awareness for a major fashion retailer, all ...

2022-01-11 08:00 3041

OneSmart International Education Group Limited Receives Notification from NYSE Regarding Delayed Form 20-F Filing

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- OneSmart International Education Group Limited ("OneSmart" or the "Company") (NYSE: ONE) today announced that it received a notice from NYSE Regulation indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual a...

2022-01-11 05:30 4945

Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct

SEATTLE, SAN FRANCISCO, SAN JOSE, Calif., NANJING, China, SUZHOU, China and SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmace...

2022-01-11 05:30 4678

SKF acquires additive manufacturing company

GOTHENBURG, Sweden, Jan. 11, 2022 /PRNewswire/ -- SKF has completed the acquisition of Laser Cladding Venture n.v. (LCV), an additive manufacturing company based inBelgium. LCV is a niche engineering start-up specialized in various additive manufacturing technologies and processes, which can be ...

2022-01-11 00:15 4597

Trajan Group acquires Neoteryx LLC

MELBOURNE, Australia, Jan. 10, 2022 /PRNewswire/ -- Global analytical science and device company Trajan Group Holdings Limited (ASX: TRJ) (Trajan or the Company) has completed the acquisition of Neoteryx, LLC (Neoteryx), a global leader in blood microsampling devices based inTorrance, California,...

2022-01-11 00:00 3140

Buybacks of series B shares in AB Electrolux during week 01, 2022

STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- During the period January 03 - January 07, 2022 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 342,312 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize ...

2022-01-10 22:56 2651

TuanChe Expands into EV Market, Differentiating Itself from Competitors with A Strong Sales Network

BEIJING, Jan. 10, 2022 /PRNewswire/ -- Beijing-based automotive marketplace, TuanChe Limited (NASDAQ: TC), recently announced the establishment of an electric vehicle (EV) business unit as part of its efforts to enter the EV manufacturing sector by working with a diverse team of EV designers, R&D...

2022-01-10 22:29 4533

CARsgen Announces CT041 CAR T-cell Product Candidate Granted RMAT Designation by the FDA

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company mainly focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, today announced thatthe United States Food and Drug Administration (FDA)...

2022-01-10 21:50 3502

Everest Medicines Will Participate in a Clinical Trial with Gilead and MSD to Evaluate Trodelvy® in Combination with KEYTRUDA® (pembrolizumab) in First-Line Metastatic Non-Small Cell Lung Cancer

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), today announced it will participate in a study pursuant to a clinical trial collaboration between Gilead and MSD (Merck & Co., Inc.,  Kenilworth, N...

2022-01-10 21:35 4834

Invitation to Autoliv's Q4, 2021 Earnings Call

STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- Autoliv Inc., plans to publish its Financial Report for the fourth quarter 2021 onFriday, January 28, 2022 at 12:00 Central European Time (CET). The report will be available at www.autoliv.com In addition, a teleconference will take place the same day. T...

2022-01-10 21:22 2692

Bigtincan Announces Bigtincan for Salesforce on Salesforce AppExchange, the World's Leading Enterprise Cloud Marketplace

Bigtincan's customers can now benefit from a powerful recommendation engine  WALTHAM, Mass., Jan. 10, 2022 /PRNewswire/ -- Bigtincan® (ASX:BTH), a global leader in sales enablement automation, today announced the general availability of Bigtincan for Salesforce on Salesforce AppExchange, empoweri...

2022-01-10 21:12 2035

Bigtincan Announces Bigtincan for Salesforce on Salesforce AppExchange, the World's Leading Enterprise Cloud Marketplace

Bigtincan's customers can now benefit from a powerful recommendation engine  WALTHAM, Mass., Jan. 10, 2022 /PRNewswire/ -- Bigtincan® (ASX:BTH), a global leader in sales enablement automation, today announced the general availability of Bigtincan for Salesforce on Salesforce AppExchange, empoweri...

2022-01-10 21:12 2454

Clinical study on Bactiguard's endotracheal tube now published - shows significant reduction of ventilator-associated pneumonia

STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- The VITAL study, by Professor Pierre Damas and his team, is now published in the well renowned journal Annals of Intensive Care. The study shows a 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube. It was presented for th...

2022-01-10 20:57 2221

Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business

BOSTON and LAUSANNE, Switzerland, Jan. 10, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their leadership team with the hiring of Peter Casasanto as Chief B...

2022-01-10 20:28 2852

Roundup from Tuya Smart Booth at 2022 CES

LAS VEGAS, Jan. 10, 2022 /PRNewswire/ -- Every January, the annual CES (Consumer Electronics Show) inLas Vegas draws top business professionals from a range of sectors around the world to promote the future of consumer technology. At this year's show, from January 5 through 7, Tuya Smart (NYSE: T...

2022-01-10 20:00 3286

Clarivate Announces Change in Leadership Structure

LONDON, Jan. 10, 2022 /PRNewswire/ -- Clarivate plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that as part of its One Clarivate Vision to put even greater focus on its customers and solutions, effectiveFebruar...

2022-01-10 20:00 2602

ChipMOS REPORTS 19.1% YoY INCREASE IN FY21 REVENUE; 3.4% YoY INCREASE IN DECEMBER 2021 MONTHLY REVENUE; 7.6% YoY INCREASE IN 4Q21 QUARTERLY REVENUE

HSINCHU, Jan. 10, 2022 /PRNewswire/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"), today re...

2022-01-10 19:00 4777

China Telecom's Annual Report Received 20 Gold Awards in Total Together with Two Grand Awards in International ARC Awards

HONG KONG, Jan. 10, 2022 /PRNewswire/ -- China Telecom Corporation Limited ("China Telecom" or "the Company"; HKEx: 00728; SSE: 601728) is pleased to announce that the print and online versions of its 2020 Annual Report " Digitalising the Future" received 11 gold awards in total in this year's In...

2022-01-10 17:21 6478

GoodWe rebrands, highlighting the role of smart tech in transforming the future of energy

SUZHOU, China, Jan. 10, 2022 /PRNewswire/ -- GoodWe has refreshed its brand in line with the evolution of the global new energy space, emphasizing on collaboration and digitalization. At the core of this new brand identity is GoodWe's commitment to harnessing smart tech to drive the global energy...

2022-01-10 16:30 4464

Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report

Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma Report also examines key therapeutic development areas to watch including mRNA, CRISPR, AI-driven drug discovery and more LONDON, Jan. 10, 2022 /...

2022-01-10 16:00 3178